- Author:
Hyo Seop AHN
1
;
Hee Young SHIN
Author Information
- Publication Type:Review
- Keywords: Umbilical cord blood; transplantation; stem cell
- MeSH: Fetal Blood*; Humans; Insurance; Korea; Stem Cells; Transplantation; Umbilical Cord*
- From:Immune Network 2003;3(2):83-88
- CountryRepublic of Korea
- Language:English
- Abstract: The number of umbilical cord blood transplantation is increasing worldwide as it has expanded the ability of the transplantaion community to meet the growing needs of their patients. Clinical data over the last decade show promising results in transplantation using both related as well as unrelated cord bloods. Cord blood banks are essential for the clinical use for transplantation and are now established around the world with the major efforts to standardize banking in collection, processing and distribution of cord blood for providing the highest quality stem cells for the patients. In Korea, Medipost, Histostem and some regional cord blood banks were established some years ago and collected thousands of cord blood for public but it had some limitations and was not expanded as the cord blood transplantation was not covered by medical insurance. Recently with the change in the policy of medical insurance to cover the cord blood transplantation, several venture companies are showing great interests in cord blood banking and trying to establish private cord blood banks in Korea. This review article discusses the current status of cord blood transplantaion and also the clincial use of stem cells from cord blood.